| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| GRF.MC - Grifols SA | HOLD | 0 @ 10.065 | 0 | |
| DIA.MI - DiaSorin SpA | SELL | -20 @ 100.9 | -2,018 | The ETF sold 20 shares of DIA.MI on 2025-03-10. The shares were previously bought for an average price of 100.333. The DiaSorin SpA shares were sold for 0.6% higher than average price of previous purchases. This sale made a profit of 11 The average price that the ETF previously sold DIA.MI share for is so the ETF has sold 20 shares on 2025-03-10 at a higher price than the previous selling average. |
| AMP.MI - Amplifon SpA | SELL | -109 @ 21.29 | -2,321 | The ETF sold 109 shares of AMP.MI on 2025-03-10. The shares were previously bought for an average price of 24.7876. The Amplifon SpA shares were sold for -14.1% lower than average price of previous purchases. This resulted in an overall loss of 381 The average price that the ETF previously sold AMP.MI share for is so the ETF has sold 109 shares on 2025-03-10 at a higher price than the previous selling average. |
| DEMANT.CO - | SELL | -78 @ 34.4577 | -2,688 | The ETF sold 78 shares of DEMANT.CO on 2025-03-10. The shares were previously bought for an average price of 35.2402. The shares were sold for -2.2% lower than average price of previous purchases. This resulted in an overall loss of 61 The average price that the ETF previously sold DEMANT.CO share for is so the ETF has sold 78 shares on 2025-03-10 at a higher price than the previous selling average. |
| IPN.PA - Ipsen SA | SELL | -33 @ 110 | -3,630 | The ETF sold 33 shares of IPN.PA on 2025-03-10. The shares were previously bought for an average price of 110.607. The Ipsen SA shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of 20 The average price that the ETF previously sold IPN.PA share for is so the ETF has sold 33 shares on 2025-03-10 at a higher price than the previous selling average. |
| HIK.L - | SELL | -145 @ 25.2176 | -3,657 | The ETF sold 145 shares of HIK.L on 2025-03-10. The shares were previously bought for an average price of 24.7278. The shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of 71 The average price that the ETF previously sold HIK.L share for is so the ETF has sold 145 shares on 2025-03-10 at a higher price than the previous selling average. |
| ZEAL.CO - | SELL | -55 @ 68.0439 | -3,742 | The ETF sold 55 shares of ZEAL.CO on 2025-03-10. The shares were previously bought for an average price of 96.3373. The shares were sold for -29.4% lower than average price of previous purchases. This resulted in an overall loss of 1,556 The average price that the ETF previously sold ZEAL.CO share for is so the ETF has sold 55 shares on 2025-03-10 at a higher price than the previous selling average. |
| BIM.PA - BioMerieux | SELL | -36 @ 117.6 | -4,234 | The ETF sold 36 shares of BIM.PA on 2025-03-10. The shares were previously bought for an average price of 103.835. The BioMerieux shares were sold for 13.3% higher than average price of previous purchases. This sale made a profit of 496 The average price that the ETF previously sold BIM.PA share for is so the ETF has sold 36 shares on 2025-03-10 at a higher price than the previous selling average. |
| SOBI.ST - | SELL | -168 @ 27.0713 | -4,548 | The ETF sold 168 shares of SOBI.ST on 2025-03-10. The shares were previously bought for an average price of 27.7773. The shares were sold for -2.5% lower than average price of previous purchases. This resulted in an overall loss of 119 The average price that the ETF previously sold SOBI.ST share for is so the ETF has sold 168 shares on 2025-03-10 at a higher price than the previous selling average. |
| DIM.PA - Sartorius Stedim Biotech | SELL | -25 @ 188.25 | -4,706 | The ETF sold 25 shares of DIM.PA on 2025-03-10. The shares were previously bought for an average price of 188.831. The Sartorius Stedim Biotech shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of 15 The average price that the ETF previously sold DIM.PA share for is so the ETF has sold 25 shares on 2025-03-10 at a higher price than the previous selling average. |
| ORNBV.HE - Orion Oyj | SELL | -94 @ 54 | -5,076 | The ETF sold 94 shares of ORNBV.HE on 2025-03-10. The shares were previously bought for an average price of 45.9285. The Orion Oyj shares were sold for 17.6% higher than average price of previous purchases. This sale made a profit of 759 The average price that the ETF previously sold ORNBV.HE share for is so the ETF has sold 94 shares on 2025-03-10 at a higher price than the previous selling average. |
| SRT3.DE - Sartorius AG | SELL | -23 @ 225.7 | -5,191 | The ETF sold 23 shares of SRT3.DE on 2025-03-10. The shares were previously bought for an average price of 222.467. The Sartorius AG shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of 74 The average price that the ETF previously sold SRT3.DE share for is so the ETF has sold 23 shares on 2025-03-10 at a higher price than the previous selling average. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | SELL | -99 @ 54.1 | -5,356 | The ETF sold 99 shares of REC.MI on 2025-03-10. The shares were previously bought for an average price of 52.9455. The Recordati Industria Chimica e Farmaceutica SpA shares were sold for 2.2% higher than average price of previous purchases. This sale made a profit of 114 The average price that the ETF previously sold REC.MI share for is so the ETF has sold 99 shares on 2025-03-10 at a higher price than the previous selling average. |
| ERF.PA - Eurofins Scientific SE | SELL | -117 @ 52.24 | -6,112 | The ETF sold 117 shares of ERF.PA on 2025-03-10. The shares were previously bought for an average price of 48.5105. The Eurofins Scientific SE shares were sold for 7.7% higher than average price of previous purchases. This sale made a profit of 436 The average price that the ETF previously sold ERF.PA share for is so the ETF has sold 117 shares on 2025-03-10 at a higher price than the previous selling average. |
| QIA.DE - QIAGEN NV | SELL | -186 @ 36.525 | -6,794 | The ETF sold 186 shares of QIA.DE on 2025-03-10. The shares were previously bought for an average price of 37.679. The QIAGEN NV shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of 215 The average price that the ETF previously sold QIA.DE share for is so the ETF has sold 186 shares on 2025-03-10 at a higher price than the previous selling average. |
| GALD.SW - | SELL | -72 @ 101.045 | -7,275 | The ETF sold 72 shares of GALD.SW on 2025-03-10. The shares were previously bought for an average price of 99.0685. The shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of 142 The average price that the ETF previously sold GALD.SW share for is so the ETF has sold 72 shares on 2025-03-10 at a higher price than the previous selling average. |
| FME.DE - Fresenius Medical Care AG | SELL | -177 @ 44.3 | -7,841 | The ETF sold 177 shares of FME.DE on 2025-03-10. The shares were previously bought for an average price of 44.3285. The Fresenius Medical Care AG shares were sold for -0.1% lower than average price of previous purchases. This resulted in an overall loss of 5 The average price that the ETF previously sold FME.DE share for is so the ETF has sold 177 shares on 2025-03-10 at a higher price than the previous selling average. |
| RO.SW - | SELL | -28 @ 339.818 | -9,515 | The ETF sold 28 shares of RO.SW on 2025-03-10. The shares were previously bought for an average price of 298.891. The shares were sold for 13.7% higher than average price of previous purchases. This sale made a profit of 1,146 The average price that the ETF previously sold RO.SW share for is so the ETF has sold 28 shares on 2025-03-10 at a higher price than the previous selling average. |
| SN.L - Smith & Nephew PLC | SELL | -715 @ 13.8292 | -9,888 | The ETF sold 715 shares of SN.L on 2025-03-10. The shares were previously bought for an average price of 12.9571. The Smith & Nephew PLC shares were sold for 6.7% higher than average price of previous purchases. This sale made a profit of 624 The average price that the ETF previously sold SN.L share for is so the ETF has sold 715 shares on 2025-03-10 at a higher price than the previous selling average. |
| COLO-B.CO - | SELL | -108 @ 100.155 | -10,817 | The ETF sold 108 shares of COLO-B.CO on 2025-03-10. The shares were previously bought for an average price of 105.344. The shares were sold for -4.9% lower than average price of previous purchases. This resulted in an overall loss of 560 The average price that the ETF previously sold COLO-B.CO share for is so the ETF has sold 108 shares on 2025-03-10 at a higher price than the previous selling average. |
| GMAB.CO - | SELL | -54 @ 204.065 | -11,020 | The ETF sold 54 shares of GMAB.CO on 2025-03-10. The shares were previously bought for an average price of 203.447. The shares were sold for 0.3% higher than average price of previous purchases. This sale made a profit of 33 The average price that the ETF previously sold GMAB.CO share for is so the ETF has sold 54 shares on 2025-03-10 at a higher price than the previous selling average. |
| STMN.SW - | SELL | -96 @ 122.276 | -11,738 | The ETF sold 96 shares of STMN.SW on 2025-03-10. The shares were previously bought for an average price of 124.037. The shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of 169 The average price that the ETF previously sold STMN.SW share for is so the ETF has sold 96 shares on 2025-03-10 at a higher price than the previous selling average. |
| SHL.DE - Siemens Healthineers AG | SELL | -243 @ 51.94 | -12,621 | The ETF sold 243 shares of SHL.DE on 2025-03-10. The shares were previously bought for an average price of 51.8309. The Siemens Healthineers AG shares were sold for 0.2% higher than average price of previous purchases. This sale made a profit of 27 The average price that the ETF previously sold SHL.DE share for is so the ETF has sold 243 shares on 2025-03-10 at a higher price than the previous selling average. |
| SOON.SW - | SELL | -44 @ 289.254 | -12,727 | The ETF sold 44 shares of SOON.SW on 2025-03-10. The shares were previously bought for an average price of 314.261. The shares were sold for -8.0% lower than average price of previous purchases. This resulted in an overall loss of 1,100 The average price that the ETF previously sold SOON.SW share for is so the ETF has sold 44 shares on 2025-03-10 at a higher price than the previous selling average. |
| SDZ.SW - | SELL | -359 @ 38.2112 | -13,718 | The ETF sold 359 shares of SDZ.SW on 2025-03-10. The shares were previously bought for an average price of 40.6275. The shares were sold for -5.9% lower than average price of previous purchases. This resulted in an overall loss of 867 The average price that the ETF previously sold SDZ.SW share for is so the ETF has sold 359 shares on 2025-03-10 at a higher price than the previous selling average. |
| FRE.DE - Fresenius SE & Co KGaA | SELL | -363 @ 39.3 | -14,266 | The ETF sold 363 shares of FRE.DE on 2025-03-10. The shares were previously bought for an average price of 34.2976. The Fresenius SE & Co KGaA shares were sold for 14.6% higher than average price of previous purchases. This sale made a profit of 1,816 The average price that the ETF previously sold FRE.DE share for is so the ETF has sold 363 shares on 2025-03-10 at a higher price than the previous selling average. |
| MRK.DE - Merck KGaA | SELL | -111 @ 134.55 | -14,935 | The ETF sold 111 shares of MRK.DE on 2025-03-10. The shares were previously bought for an average price of 139.551. The Merck KGaA shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of 555 The average price that the ETF previously sold MRK.DE share for is so the ETF has sold 111 shares on 2025-03-10 at a higher price than the previous selling average. |
| PHIA.AS - Koninklijke Philips NV | SELL | -687 @ 24.9 | -17,106 | The ETF sold 687 shares of PHIA.AS on 2025-03-10. The shares were previously bought for an average price of 24.6046. The Koninklijke Philips NV shares were sold for 1.2% higher than average price of previous purchases. This sale made a profit of 203 The average price that the ETF previously sold PHIA.AS share for is so the ETF has sold 687 shares on 2025-03-10 at a higher price than the previous selling average. |
| UCB.BR - UCB SA | SELL | -109 @ 169.4 | -18,465 | The ETF sold 109 shares of UCB.BR on 2025-03-10. The shares were previously bought for an average price of 187.048. The UCB SA shares were sold for -9.4% lower than average price of previous purchases. This resulted in an overall loss of 1,924 The average price that the ETF previously sold UCB.BR share for is so the ETF has sold 109 shares on 2025-03-10 at a higher price than the previous selling average. |
| BAYN.DE - Bayer AG | SELL | -845 @ 23.555 | -19,904 | The ETF sold 845 shares of BAYN.DE on 2025-03-10. The shares were previously bought for an average price of 20.0857. The Bayer AG shares were sold for 17.3% higher than average price of previous purchases. This sale made a profit of 2,932 The average price that the ETF previously sold BAYN.DE share for is so the ETF has sold 845 shares on 2025-03-10 at a higher price than the previous selling average. |
| ARGX.BR - Argenx SE | SELL | -52 @ 531.2 | -27,622 | The ETF sold 52 shares of ARGX.BR on 2025-03-10. The shares were previously bought for an average price of 595.286. The Argenx SE shares were sold for -10.8% lower than average price of previous purchases. This resulted in an overall loss of 3,332 The average price that the ETF previously sold ARGX.BR share for is so the ETF has sold 52 shares on 2025-03-10 at a higher price than the previous selling average. |
| HLN.L - Haleon PLC | SELL | -7,397 @ 4.73634 | -35,035 | The ETF sold 7397 shares of HLN.L on 2025-03-10. The shares were previously bought for an average price of 4.78282. The Haleon PLC shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of 344 The average price that the ETF previously sold HLN.L share for is so the ETF has sold 7397 shares on 2025-03-10 at a higher price than the previous selling average. |
| LONN.SW - | SELL | -62 @ 569.713 | -35,322 | The ETF sold 62 shares of LONN.SW on 2025-03-10. The shares were previously bought for an average price of 578.592. The shares were sold for -1.5% lower than average price of previous purchases. This resulted in an overall loss of 550 The average price that the ETF previously sold LONN.SW share for is so the ETF has sold 62 shares on 2025-03-10 at a higher price than the previous selling average. |
| ALC.SW - | SELL | -430 @ 83.8971 | -36,076 | The ETF sold 430 shares of ALC.SW on 2025-03-10. The shares were previously bought for an average price of 82.9152. The shares were sold for 1.2% higher than average price of previous purchases. This sale made a profit of 422 The average price that the ETF previously sold ALC.SW share for is so the ETF has sold 430 shares on 2025-03-10 at a higher price than the previous selling average. |
| GSK.L - GlaxoSmithKline PLC | SELL | -3,565 @ 18.556 | -66,152 | The ETF sold 3565 shares of GSK.L on 2025-03-10. The shares were previously bought for an average price of 16.4181. The GlaxoSmithKline PLC shares were sold for 13.0% higher than average price of previous purchases. This sale made a profit of 7,622 The average price that the ETF previously sold GSK.L share for is so the ETF has sold 3565 shares on 2025-03-10 at a higher price than the previous selling average. |
| EL.PA - EssilorLuxottica SA | SELL | -256 @ 273.3 | -69,965 | The ETF sold 256 shares of EL.PA on 2025-03-10. The shares were previously bought for an average price of 242.813. The EssilorLuxottica SA shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of 7,805 The average price that the ETF previously sold EL.PA share for is so the ETF has sold 256 shares on 2025-03-10 at a higher price than the previous selling average. |
| SAN.PA - Sanofi SA | SELL | -978 @ 109.48 | -107,071 | The ETF sold 978 shares of SAN.PA on 2025-03-10. The shares were previously bought for an average price of 94.8468. The Sanofi SA shares were sold for 15.4% higher than average price of previous purchases. This sale made a profit of 14,311 The average price that the ETF previously sold SAN.PA share for is so the ETF has sold 978 shares on 2025-03-10 at a higher price than the previous selling average. |
| NOVN.SW - | SELL | -1,695 @ 106.133 | -179,895 | The ETF sold 1695 shares of NOVN.SW on 2025-03-10. The shares were previously bought for an average price of 96.6039. The shares were sold for 9.9% higher than average price of previous purchases. This sale made a profit of 16,152 The average price that the ETF previously sold NOVN.SW share for is so the ETF has sold 1695 shares on 2025-03-10 at a higher price than the previous selling average. |
| AZN.L - AstraZeneca PLC | SELL | -1,334 @ 140.995 | -188,087 | The ETF sold 1334 shares of AZN.L on 2025-03-10. The shares were previously bought for an average price of 129.373. The AstraZeneca PLC shares were sold for 9.0% higher than average price of previous purchases. This sale made a profit of 15,504 The average price that the ETF previously sold AZN.L share for is so the ETF has sold 1334 shares on 2025-03-10 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -604 @ 321.812 | -194,374 | The ETF sold 604 shares of ROG.SW on 2025-03-10. The shares were previously bought for an average price of 281.34. The shares were sold for 14.4% higher than average price of previous purchases. This sale made a profit of 24,445 The average price that the ETF previously sold ROG.SW share for is so the ETF has sold 604 shares on 2025-03-10 at a higher price than the previous selling average. |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -2,770 @ 73.6617 | -204,043 | The ETF sold 2770 shares of NOVO-B.CO on 2025-03-10. The shares were previously bought for an average price of 86.2643. The Novo Nordisk A/S shares were sold for -14.6% lower than average price of previous purchases. This resulted in an overall loss of 34,909 The average price that the ETF previously sold NOVO-B.CO share for is so the ETF has sold 2770 shares on 2025-03-10 at a higher price than the previous selling average. |